{
    "clinical_study": {
        "@rank": "30006", 
        "acronym": "OPEN", 
        "arm_group": {
            "arm_group_label": "Device Treatment", 
            "arm_group_type": "Experimental", 
            "description": "Tongue Advancement Retainer Device"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the safety and efficacy of the Tongue Advancement Retainer Device in treating\n      subjects with Obstructive Sleep Apnea (OSA) and snoring."
        }, 
        "brief_title": "A Trial to Evaluate a Device for the Treatment of OSA and Snoring", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obstructive Sleep Apnea", 
            "Snoring"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Snoring", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Tongue Advancement Retainer Device is a device that was developed to treat subjects with\n      OSA and snoring.  The purpose of this study is to evaluate initial safety and effectiveness\n      of this device in treating one or both conditions."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 Aged 18-65\n\n               -  AHI greater than or equal to 10 but less than or equal to 60 (<10 AHI <60/hr)\n\n               -  Complete set of lower anterior incisors with no evidence of periodontal disease\n                  or mobility and the ability to floss between teeth\n\n        Additionally subjects will in the screening phase must:\n\n          -  Tolerate the device when being fitted\n\n          -  Used the device for >4 hours on at least two consecutive nights during the screening\n             period.\n\n          -  Be able to reliably demonstrate proper installation of the device after fitting.\n\n          -  Be willing to trial the device for a 4 week period\n\n        Exclusion Criteria:\n\n          -  \u2022 Central sleep apnea events >10% of the total events\n\n               -  Evidence of Cheyne stokes breathing\n\n               -  Currently on treatment for OSA or OSA treatment discontinued less than 3 months\n                  prior.\n\n               -  Currently on regular treatment with prescription hypnosedatives  or\n                  prescription stimulants\n\n               -  Very severe OSA, defined as AHI>60/hour and/or minimum oxygen saturation <75%\n\n               -  Need for immediate initiation of treatment as assessed by physician (e.g.\n                  Excessive sleepiness posing driving risk)\n\n               -  Previous surgery to treat OSA (other than nasal surgery)\n\n               -  Evidence of periodontal disease or tooth mobility\n\n               -  Severe nasal obstruction or enlarged tonsils based on clinical assessment\n\n               -  Unstable cardiovascular disease (untreated hypertension acceptable).\n\n               -  Inability to tolerate oral device due to oral condition or claustrophobia as\n                  determined by the study investigator\n\n               -  Pregnant/Breast Feeding\n\n               -  Any known factor or disease that might interfere with treatment compliance,\n                  study conduct or interpretation of the results such as co-existent other sleep\n                  disorder, psychiatric disease, history of non compliance to medical regimens, or\n                  unwillingness to comply with study requirements."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01772017", 
            "org_study_id": "OPEN-002"
        }, 
        "intervention": {
            "arm_group_label": "Device Treatment", 
            "description": "Tongue Advancement Retainer Device", 
            "intervention_name": "Tongue Advancement Retainer Device", 
            "intervention_type": "Device", 
            "other_name": "Sleepy Tongue Advancement Retainer Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obstructive Sleep Apnea", 
            "OSA", 
            "Snoring", 
            "Tongue Advancement Retainer Device"
        ], 
        "lastchanged_date": "July 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92120"
                    }, 
                    "name": "Senta Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Visalia", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93291"
                    }, 
                    "name": "Visalia Medical Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Leonards", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2065"
                    }, 
                    "name": "Royal North Shore Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi Center, Open Label Study to Evaluate a Tongue Advancement Retainer Device in the Treatment of Subjects With Obstructive Sleep Apnea and Snoring (OPEN Trial)", 
        "overall_official": {
            "affiliation": "Senta Clinic", 
            "last_name": "Brian Weeks, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety endpoint will be measured throughout the duration of the study.", 
            "measure": "Primary Safety Endpoint - The safety of the device will be measured through recorded observations of adverse events.", 
            "safety_issue": "Yes", 
            "time_frame": "Approximately 6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01772017"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Efficacy Endpoint will be measured at baseline and at end of treatment.", 
            "measure": "Primary Efficacy Endpoint - Change in the overall Apnea Hypopnea Index (AHI) from the PSG at baseline and end of treatment phase.", 
            "safety_issue": "No", 
            "time_frame": "Approximately 6 weeks"
        }, 
        "source": "Sleepy, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sleepy, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}